We are live on
!
Find out more
VFA
Virtus Fund Advisers Portfolio holdings
AUM
$32.1M
1-Year Est. Return
39.5%
This Fund
S&P 500
This Quarter
Est. Return
+0.38%
1 Year Est. Return
+39.5%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$10.1B
AUM Growth
-$489M
(-4.6%)
Cap. Flow
-$516M
Cap. Flow
% of AUM
-5.11%
Top 10 Holdings %
Top 10 Hldgs %
11.15%
Holding
560
New
32
Increased
113
Reduced
251
Closed
39
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zimmer Biomet
ZBH
|
+$78.6M |
| 2 |
Halliburton
HAL
|
+$65.7M |
| 3 |
PXD
Pioneer Natural Resource Co.
PXD
|
+$64.4M |
| 4 |
Campbell Soup
CPB
|
+$62M |
| 5 |
Perrigo
PRGO
|
+$58.1M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Fair Isaac
FICO
|
+$176M |
| 2 |
Cigna
CI
|
+$122M |
| 3 |
ExxonMobil
XOM
|
+$111M |
| 4 |
Willis Towers Watson
WTW
|
+$108M |
| 5 |
Ralph Lauren
RL
|
+$78.6M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Financials | 16.1% |
| 2 | Industrials | 14.51% |
| 3 | Technology | 10.22% |
| 4 | Consumer Discretionary | 10.01% |
| 5 | Energy | 8.79% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
376
Amgen
AMGN
$209B
| $260K | ﹤0.01% |
1,519
| – | – |
|
|
CLVS
377
DELISTED
Clovis Oncology, Inc.
CLVS
| $258K | ﹤0.01% |
+2,697
| New | +$165K |
|
|
CRZO
378
DELISTED
Carrizo Oil & Gas Inc
CRZO
| $252K | ﹤0.01% |
16,463
-491
| -3% | -$11.4K |
|
|
DERM
379
DELISTED
Dermira, Inc.
DERM
| $246K | ﹤0.01% |
8,443
-252
| -3% | -$7.66K |
|
380
Dorman Products
DORM
$4.22B
| $244K | ﹤0.01% |
3,181
-3,427
| -52% | -$280K |
|
|
LJPC
381
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $238K | ﹤0.01% |
7,396
-220
| -3% | -$6.3K |
|
382
Nike
NKE
$64.1B
| $236K | ﹤0.01% |
4,078
| – | – |
|
383
AMERISAFE
AMSF
$562M
| $235K | ﹤0.01% |
4,192
-4,523
| -52% | -$258K |
|
384
Boeing
BA
$169B
| $223K | ﹤0.01% |
1,103
-200
| -15% | -$37.2K |
|
385
PBF Energy
PBF
$7.49B
| $223K | ﹤0.01% |
10,037
-299
| -3% | -$6.42K |
|
386
Inogen
INGN
$174M
| $222K | ﹤0.01% |
2,343
-8,568
| -79% | -$732K |
|
387
iShares Russell 2000 ETF
IWM
$79.1B
| $221K | ﹤0.01% |
1,568
-65
| -4% | -$9K |
|
388
Sinclair Inc
SBGI
$1.02B
| $219K | ﹤0.01% |
+6,666
| New | +$240K |
|
389
Union Pacific
UNP
$174B
| $219K | ﹤0.01% |
2,022
| – | – |
|
|
PRAH
390
DELISTED
PRA Health Sciences, Inc.
PRAH
| $215K | ﹤0.01% |
+2,852
| New | +$198K |
|
391
Prudential Financial
PRU
$42.6B
| $209K | ﹤0.01% |
1,877
| – | – |
|
|
TSRO
392
DELISTED
TESARO, Inc.
TSRO
| $209K | ﹤0.01% |
1,553
-835
| -35% | -$121K |
|
393
iShares MSCI Europe Small-Cap ETF
IEUS
$177M
| $203K | ﹤0.01% |
3,911
| – | – |
|
|
BMCH
394
DELISTED
BMC Stock Holdings, Inc
BMCH
| $202K | ﹤0.01% |
+9,372
| New | +$204K |
|
395
Duke Energy
DUK
$101B
| $192K | ﹤0.01% |
2,301
| – | – |
|
396
Penumbra
PEN
$12.6B
| $192K | ﹤0.01% |
+2,153
| New | +$183K |
|
|
DOOR
397
DELISTED
MASONITE INTERNATIONAL CORP
DOOR
| $190K | ﹤0.01% |
+2,550
| New | +$196K |
|
398
Elevance Health
ELV
$81.5B
| $189K | ﹤0.01% |
988
| – | – |
|
399
Monro
MNRO
$414M
| $188K | ﹤0.01% |
4,602
-1,768
| -28% | -$88.1K |
|
400
Starbucks
SBUX
$119B
| $185K | ﹤0.01% |
3,188
-278,426
| -99% | -$16.8M |
|
Similar funds
VCM
CGI
SFM
CIA
SL
OAM
MFAM
AH
Virtus Fund Advisers's Q2 2017 Portfolio in Review
As of Q2 2017, Virtus Fund Advisers held 560 positions worth $10.1B, down 4.6% from $10.6B the previous quarter. Its ten largest holdings account for 11% of the portfolio.
Virtus Fund Advisers withdrew a net $516M in Q2 2017, closing 39 positions and reducing 251 holdings. Its most notable exit was Willis Towers Watson, an estimated $108M position sold in full.
By sector, the portfolio is most concentrated in Financials at 16% of assets, down from 17% a quarter earlier, followed by Industrials and Technology.
Against the trend, Virtus Fund Advisers opened a new position in Campbell Soup worth $56.5M.
- Virtus Fund Advisers's largest Q2 2017 buy was Campbell Soup: 1,095,493 shares worth $56.5M.
- Virtus Fund Advisers added most to Zimmer Biomet in Q2 2017, an estimated $78.6M increase.
- Virtus Fund Advisers's biggest Q2 2017 reduction was Fair Isaac, cutting an estimated $176M.
- Virtus Fund Advisers fully exited Willis Towers Watson in Q2 2017, selling an estimated $108M.
- Virtus Fund Advisers's ten largest holdings make up 11% of its $10.1B portfolio in Q2 2017.
- Virtus Fund Advisers opened 32 new positions and closed 39 in Q2 2017.
- Virtus Fund Advisers's portfolio value fell 4.6% quarter-over-quarter to $10.1B.
Based on Virtus Fund Advisers's 13F filing for Q2 2017, filed 11 Aug 2017.